News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Iroko Pharmaceuticals Granted Key Patent For TIVORBEX™



5/28/2014 10:14:25 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PHILADELPHIA--(BUSINESS WIRE)--Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today the issuance of the first patent for the composition of matter and formulation of TIVORBEX™ (indomethacin) capsules by the United States Patent and Trademark Office (USPTO). The company also received a second patent for ZORVOLEX® (diclofenac) capsules covering its manufacturing method. ZORVOLEX and TIVORBEX were approved in October 2013 and February 2014, respectively, by the U.S. Food and Drug Administration (FDA) for the treatment of mild to moderate acute pain in adults.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES